MENUNews Archive
Date: 08/25/2017
An experimental drug combined with the traditional chemotherapy drug cisplatin, when used in mice, destroyed a rare form of salivary gland tumor and prevented a recurrence within 300 days, a University of Michigan study found.
Date: 08/08/2017
Ranked No. 1 in Michigan and No. 12 in the country, The University of Michigan Rogel Cancer Center was recognized as among the best in the nation by U.S. News & World Report for 2017-2018.
Date: 08/02/2017
A new study shows just how complex metastatic cancer is and offers some clues to attacking it. The study represents one of the largest and most comprehensive efforts to examine the genetic and molecular landscape of advanced cancer.
Date: 07/21/2017
Michigan Medicine experts discuss whether active surveillance could reduce overtreatment for some thyroid, prostate and breast cancers
Date: 07/13/2017
Following a cancer diagnosis, all patients experience some level of distress -- regardless of disease stage. When severe and left untreated, distress can have a significant impact on health outcomes, lead to greater mortality and morbidity, affect immune function, and result in higher health care expenditures.
Date: 07/12/2017
The University of Michigan Rogel Cancer Center Research Committee recently awarded $340,000 in grants to faculty for cancer-related research.
Date: 07/12/2017
Researchers at the University of Michigan Rogel Cancer Center received more than $23 million in grants in June and July, 2017.
Date: 06/30/2017
New research out of the University of Michigan supports combining two approaches to fight back against gliomas: attacking the tumor with gene therapy while enhancing the immune system’s ability to fight it, too.
Date: 06/29/2017
In a new study, researchers used a patient's own cancer history rather than family history to identify genetic mutations that might influence cancer treatment and risk for family members.
Date: 06/27/2017
Researchers at the University of Michigan will lead one of five nationally funded centers dedicated to accelerating research into understanding the molecular basis of cancer and sharing resources with the scientific community.